Alpha Signal Monitor - Daily Market Briefing | June 17, 2026
Daily Market Research Report
June 17, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Institutional Outlook: Gold ETFs (GLD, IAU, BAR) — as of June 17, 2026
Trading Idea: Buy Rationale (TL;DR): Most top research houses still see higher gold into late‑2026 (5,400–6,300/oz targets from Goldman Sachs, J.P. Morgan Private Bank, UBS; BofA retains 6,000/oz 12‑month call). Despite volatility after January’s record highs, the structural bid from central banks, ongoing ETF inflows and a likely drift lower in real rates support accumulating broad gold ETFs (GLD, IAU, BAR) on dips for a 6–18 month horizon. (am.gs.com)
Gold surged ~65% in 2025 and set fresh all‑time highs near $5,595/oz in early 2026 before a sharp pullback. Near‑term swings reflect a stronger USD and higher real yields, but banks emphasize enduring support from central‑bank accumulation, reserve diversification and robust investor demand via ETFs. Consensus year‑end‑2026 targets cluster around $5,400–$6,300/oz, albeit with different paths and vol. (deutsche-bank.de)
Key Drivers - Central‑bank buying and reserve diversification (especially EM) continue to underpin prices into 2026. (jpmorgan.com) - Net ETF inflows re‑accelerated through 2025 and into 2026, tightening the investable float. (jpmorgan.com) - Potential easing in real rates over the next year improves gold’s relative carry versus cash/fixed income. (am.gs.com) - Macro uncertainty (geopolitics, fiscal sustainability, de‑dollarization) sustains a structural allocation bid. (privatebank.jpmorgan.com) - Banks’ published targets imply upside from current levels into late‑2026, even under more conservative houses. (am.gs.com)
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Bullish | GIR 12‑month gold at ~$5,445/oz (as of June 1, 2026); previously flagged $5,400/oz by end‑2026. | GSAM ‘Market Pulse’ shows London Gold current 4,591; 3m 4,805; 12m 5,445. A late‑April note (reported by Reuters/Investing.com) maintained 5,400 end‑2026 with near‑term downside risks. | 2026-06-01 | https://am.gs.com/cms-assets/gsam-app/documents/insights/en/2026/us-market-pulse_june2026.pdf |
| Morgan Stanley | Moderately bullish | $4,800/oz by Q4‑2026 (Reuters, Jan 6, 2026). | MS projects slower gains but expects rate cuts, central‑bank buying and growth concerns to support ~$4,800 by Q4‑26; earlier research had ~$4,400 mid‑2026. | 2026-01-06 | https://www.kitco.com/news/off-the-wire/2026-01-06/morgan-stanley-forecasts-gold-4800-fourth-quarter-2026 |
| JP Morgan | Bullish | $6,000–$6,300/oz by late‑2026 (Private Bank). JPM Global Research base case had 4Q26 avg near $5,055/oz. | Private Bank raised outlook to a $6,000–$6,300 range with supportive demand drivers; Global Research tables show quarterly 2026 averages rising to ~$5,055 in 4Q. | 2026-01-21 | https://privatebank.jpmorgan.com/eur/en/insights/markets-and-investing/is-it-a-golden-era-for-gold |
| Bank of America | Bullish | $6,000/oz in ~12 months (Jan 23, 2026). Earlier 2026 forecast was $5,000. | BofA (Widmer/Hartnett) set a 12‑month $6,000 target in January 2026, citing bull‑market analogs, supply constraints and portfolio‑hedge demand. | 2026-01-23 | https://www.kitco.com/news/article/2026-01-23/forget-5000-bank-america-sees-gold-price-hitting-6000oz-spring-2026 |
| Citigroup | Neutral (near‑term upside but 12‑month base case neutral‑to‑bearish) | 0–3m raised to $5,000/oz (Jan 13, 2026); base case 12‑month view neutral‑to‑bearish (Dec 4, 2025). | Citi lifted the near‑term target to $5,000 as the bull market extended, but its Research podcast set a neutral‑to‑bearish 12‑month base case with bull‑case $5,000 by end‑2026. | 2026-01-13 | https://www.kitco.com/news/article/2026-01-13/gold-will-hit-5000oz-silver-100oz-march-gold-will-be-vulnerable-correction?utm_source=openai |
| UBS | Attractive/Overweight | Lowered near‑term (Jun‑26: $5,200) but kept Dec‑26 at $5,900/oz. | UBS CIO cut the end‑June target to $5,200 on higher USD/real yields but kept medium‑term upside, forecasting $5,900 by late‑2026; maintains Attractive rating and long gold in GAA. | 2026-04-02 | https://www.ubs.com/global/en/wealthmanagement/insights/chief-investment-office/house-view/2026/weekly-key-messages/_jcr_content/root/contentarea/mainpar/toplevelgrid_1825995/col_2/textimage_copy.0398470549.file/dGV4dD0vY29udGVudC9kYW0vYXNzZXRzL3dtL2dsb2JhbC9jaW8vaG91c2Utdmlldy9kb2N1bWVudC9nb2xkLWVuLTE2NTc3MTYucGRm/gold-en-1657716.pdf |
| HSBC | Constructive long‑term; expects volatility/peaking dynamics | HSBC said gold could reach ~$5,000 in 2026; separate updates discuss near‑term volatility and longer‑term support from a softer USD. | Reuters reported HSBC’s 2026 potential near $5,000; subsequent analysis highlighted gold’s risk‑asset behavior in 2026 and longer‑term support from a weaker dollar. | 2026-04-20 | https://www.investing.com/news/economy-news/gold-to-hit-5000oz-in-2026-hsbc-says-4294167?utm_source=openai |
| Deutsche Bank | Bullish (with scenario upside) | DB reiterated gold could reach ~$6,000 in 2026; earlier avg‑2026 forecast ~$4,450/oz. | Reuters summarized DB’s late‑Jan 2026 reiteration of a ~$6,000 call alongside prior Research averages near $4,450; DB commentaries emphasize persistent investment/CB demand and geopolitics. | 2026-01-27 | https://www.marketscreener.com/news/goldman-sachs-raises-2026-end-gold-price-forecast-to-5-400-oz-ce7e58d2dc89fe24?utm_source=openai |
Risk Considerations - Stronger USD and/or higher real yields could cap rallies or trigger further liquidation (near‑term headwind cited by UBS; GS notes downside risks around risk‑asset corrections). (ubs.com) - Reversal/slowdown of central‑bank purchases or renewed ETF outflows would weaken the structural bid. (ubs.com) - Faster‑than‑expected growth/less Fed easing (Citi base case: neutral‑to‑bearish 12‑month) could cool investor demand. (citigroup.com) - Positioning and liquidity shocks can amplify drawdowns; HSBC highlights risk‑asset‑like behavior at times. (kitco.com)
Position for higher prices into late‑2026 with staged entry. Base‑to‑bull outcome bands implied by street targets: ~$4,450–$4,800 (conservative: HSBC/MS) to ~$5,900–$6,300 (UBS/JPM/BofA). For GLD/IAU/BAR, dollar‑cost average on weakness and reassess if USD/real‑yield dynamics turn decisively adverse. (kitco.com)
Stock Ratings — Street targets and ratings from GS/MS/JPM/BAC/C/WFC — As of June 17, 2026
Compiled latest publicly reported/aggregated 12‑month targets and ratings where available. Primary sources favor broker-tracking aggregators (MarketBeat, StockAnalysis) and reputable briefs (Investing.com/AppleInsider/StreetInsider). Missing items are null when no authoritative public record was found.
AAPL - Apple Inc.
Broadly positive across the six, with fresh target lifts into early June 2026; Bank of America is the Street high among this group at $380.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $340 | 2026-06-03 | Maintained Buy with a lift to $340. | https://stockanalysis.com/stocks/aapl/forecast/ |
| Morgan Stanley | Overweight | $360 | 2026-06-09 | Raised target to $360 on Apple Intelligence/Siri roadmap and catalysts. | https://ca.investing.com/news/stock-market-news/morgan-stanley-raises-apple-stock-price-target-to-360-on-ai-strategy-93CH-4681427 |
| JP Morgan | Buy | - | 2026-06-09 | Rating maintained; target not disclosed on the public trackers. | https://stockanalysis.com/stocks/aapl/forecast/ |
| Bank of America | Buy | $380 | 2026-05-26 | Raised from $330 to $380 on AI positioning. | https://appleinsider.com/articles/26/05/26/new-380-bank-of-america-aapl-target-puts-ai-in-the-spotlight |
| Citigroup | Buy | - | 2026-06-01 | Reiterated Buy; target not shown on public page. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Wells Fargo | Overweight | $310 | 2026-05-01 | Raised $300→$310 with Overweight. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
Consensus View - Rating: Buy, Target Price: $347.50 - Simple average of available targets from GS/MS/BAC/WFC.
MSFT - Microsoft Corp.
Multiple positive calls; Wells Fargo and Morgan Stanley at $650; JPM trimmed to $550 in January.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2026-04-28 | Reiterated Buy; target not displayed on public page. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Morgan Stanley | Buy | $650 | 2026-06-02 | Keith Weiss maintained $650. | https://stockanalysis.com/stocks/msft/forecast/ |
| JP Morgan | Overweight | $550 | 2026-01-29 | Trimmed PT to $550 while keeping Overweight. | https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-lowered-to-550-by-jpmorgan-on-valuation-93CH-4473038 |
| Bank of America | Buy | $500 | 2026-03-24 | Initiated coverage with Buy, $500 PT. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Citigroup | Market Outperform | - | 2026-06-01 | Initiated/maintained Market Outperform; target not shown on public page. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Wells Fargo | Overweight | $650 | 2026-06-01 | Boosted $625→$650. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
Consensus View - Rating: Buy, Target Price: $587.50 - Average of available MS/WFC/JPM/BAC targets.
GOOGL - Alphabet Inc. (Class A)
Targets broadly lifted into late April/May; BofA to $430, GS to $450; Wells Fargo at $435.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $450 | 2026-04-30 | Raised $400→$450. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Morgan Stanley | - | - | 2026-04-30 | Coverage noted; specific PT not visible on the public page. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| JP Morgan | Buy | - | 2026-05-04 | Reiterated Buy; PT not shown on the public page. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Bank of America | Buy | $430 | 2026-04-30 | Raised $370→$430. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Citigroup | Outperform | - | 2026-05-04 | Reiterated Outperform; target not shown on public page. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Wells Fargo | Overweight | $435 | 2026-05-20 | Raised $427→$435. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
Consensus View - Rating: Buy, Target Price: $438.33 - Average of available GS/BAC/WFC targets.
AMZN - Amazon.com Inc.
Morgan Stanley raised PT to $330 on 4/30/26; other banks’ latest public targets not readily visible on free pages.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | No recent public target found on free sources. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Morgan Stanley | Overweight | $330 | 2026-04-30 | Raised $300→$330. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| JP Morgan | - | - | - | Coverage active; latest PT not visible on public page. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Bank of America | - | - | - | Coverage active; latest PT not visible on public page. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Citigroup | - | - | - | Coverage active; latest PT not visible on public page. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Wells Fargo | - | - | - | Coverage active; latest PT not visible on public page. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
Consensus View - Rating: Buy, Target Price: $330.00 - Only Morgan Stanley PT available across the requested six.
NVDA - NVIDIA Corp.
Mixed but constructive: JPM to $280 (May 21), WFC to $315 (May 12); GS reiterating Buy with $250 in May.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $250 | 2026-05-07 | Reiterated Buy, $250 PT. | https://www.investing.com/news/analyst-ratings/nvidia-stock-price-target-reiterated-at-250-by-goldman-sachs-93CH-4666748 |
| Morgan Stanley | - | - | - | Latest PT not found on free sources. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| JP Morgan | Overweight | $280 | 2026-05-21 | Hoisted $265→$280. | https://www.marketbeat.com/instant-alerts/nvidia-nasdaqnvda-given-new-28000-price-target-at-jpmorgan-chase-co-2026-05-21/ |
| Bank of America | Buy | - | 2025-12-15 | Recent public recap references $275, but not confirmed on primary free pages in 2026. | https://www.reddit.com/r/NvidiaStock/comments/1pk4sqf/bofa_securities_has_reiterated_its_buy_rating_and/ |
| Citigroup | - | - | - | No recent public target located on free sources. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Wells Fargo | Overweight | $315 | 2026-05-12 | Raised $265→$315 ahead of earnings. | https://www.streetinsider.com/Analyst+Comments/NVIDIA+(NVDA)+PT+Raised+to+%24315+at+Wells+Fargo%2C+Increasing+Data+Center+Ests+Above+Consensus/26471888.html |
Consensus View - Rating: Buy, Target Price: $281.67 - Average of available GS/JPM/WFC targets.
META - Meta Platforms Inc.
Diverging views: Wells Fargo trimmed then raised to $770; Morgan Stanley lowered to $775; Goldman Sachs downgraded to Sell on June 2.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Sell | - | 2026-06-02 | Downgraded Buy→Sell; target not shown on public page. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Morgan Stanley | Overweight | $775 | 2026-03-27 | Lowered $825→$775. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| JP Morgan | Buy | - | 2026-04-30 | Coverage shown; target not visible on public page. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Bank of America | Buy | $820 | 2026-04-10 | Lowered $885→$820; maintained Buy. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Citigroup | - | - | - | Coverage present historically; latest PT not visible on public page. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Wells Fargo | Overweight | $770 | 2026-04-30 | Raised $765→$770. | https://www.marketbeat.com/instant-alerts/meta-platforms-nasdaqmeta-price-target-raised-to-77000-at-wells-fargo-company-2026-04-30/ |
Consensus View - Rating: Buy, Target Price: $788.33 - Average of available MS/BAC/WFC targets; note GS is Sell without public PT.
TSLA - Tesla Inc.
Mixed and volatile: BAC initiated Buy at $460; MS at Equal Weight $415; WFC kept Underweight with $125; JPM upgraded to Neutral in June.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | Recent public PT not found on free sources for 2026. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Morgan Stanley | Equal Weight | $415 | 2026-01-29 | Set $425→$415 Equal Weight. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| JP Morgan | Neutral | - | 2026-06-05 | Upgraded from Underweight to Neutral; public PT not shown in upgrade brief. | https://www.marketbeat.com/instant-alerts/tesla-nasdaqtsla-upgraded-by-jpmorgan-chase-co-to-neutral-rating-2026-06-05/ |
| Bank of America | Buy | $460 | 2026-02-11 | Initiated Buy with $460 PT. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Citigroup | - | - | - | Coverage active; latest PT not visible on public page. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Wells Fargo | Underweight | $125 | 2026-01-06 | Lowered $130→$125; maintained Underweight. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
Consensus View - Rating: Hold, Target Price: $333.33 - Average of available BAC/MS/WFC targets; ratings split across Buy/Neutral/Underweight.
AVGO - Broadcom Inc.
Requested banks’ latest public targets were not readily available on free sources during this pass.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Consensus View - Insufficient data across the six requested institutions.
TSM - Taiwan Semiconductor Manufacturing Co. (TSMC)
Requested banks’ latest public targets were not readily available on free sources during this pass.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Consensus View - Insufficient data across the six requested institutions.
Highlights
- Apple: MS $360 (Jun 9), GS $340 (Jun 3), BAC $380 (May 26), WFC $310 (May 1).
- Microsoft: WFC $650 (Jun 1) and MS $650 (Jun 2) lead; JPM $550 (Jan 29); BAC $500 (Mar 24).
- Alphabet: GS $450 and BAC $430 (Apr 30); WFC $435 (May 20).
- NVIDIA: JPM $280 (May 21); WFC $315 (May 12); GS $250 (May 7).
- Meta: WFC $770 (Apr 30); MS $775 (Mar 27); BAC $820 (Apr 10); GS downgraded to Sell (Jun 2).
- Tesla: BAC Buy $460 (Feb 11); MS Equal Weight $415 (Jan 29); WFC Underweight $125 (Jan 6); JPM upgraded to Neutral (Jun 5).
Notes: 1) Dates are in 2026 and reflect the most recent publicly viewable items per source. 2) Several banks’ detailed targets are often behind paid portals; where trackers didn’t expose a figure, target_price is null. 3) Consensus here is a simple average of the available targets from the six named institutions only; it is not the full Street consensus.
IPO Calendar
Timeframe: June 17, 2026 to July 17, 2026 (US equity markets)
Following June’s blockbuster pricings, the next month’s US IPO slate skews smaller-to-mid cap with a mix of healthcare, financials, industrials and cross‑border tech listings. Near term, June 18 features a community bank (FCBM) and a late‑stage cardiovascular biotech (KARD), with a SPAC (TVIV) and a small optics hardware issuer (MOT) also on the docket. The largest scheduled deal in this window is Doncasters/DPC Holdings (aerospace superalloys) launching a ~$700 million NYSE offering the week of June 24. Dates beyond late June remain fluid because issuers typically set pricing/listing dates only 7–10 days in advance; several smaller names have set terms and may slot into late June/early July subject to market conditions. (renaissancecapital.com)
First Carolina Financial Services, Inc. (FCBM)
- Expected listing date: 2026-06-18
- Price range: $14–$16
- Shares offered: 5,500,000 shares (primary)
- Exchange: NYSE
- Lead underwriters: Keefe, Bruyette & Woods (KBW)
- Business summary: Regional bank holding company for First Carolina Bank serving NC, SC, GA, and VA with a national financial services platform. As of March 31, 2026, it reported ~$3.4B in assets, ~$2.7B in loans, ~$3.0B in deposits, and over 524,000 customer deposit accounts; IPO proceeds support capital and growth. (renaissancecapital.com)
- Notes: S-1/A filed in June; timing and final terms subject to change. Listing symbol FCBM per filings. (sec.gov)
- Sources: Renaissance Capital — US IPO Week Ahead (June 12, 2026), SEC — First Carolina Financial Services Form S-1/S-1A (May–June 2026)
Kardigan, Inc. (KARD)
- Expected listing date: 2026-06-18
- Price range: $14–$16
- Shares offered: 23,333,334 shares (primary)
- Exchange: Nasdaq
- Lead underwriters: J.P. Morgan, Jefferies, Leerink Partners, TD Cowen
- Business summary: Clinical‑stage precision therapeutics company developing multiple cardiovascular candidates, including danicamtiv (oral cardiac myosin activator; Ph2b/3), ataciguat (sGC activator; Ph2b for calcific aortic valve stenosis), and tonlamarsen (antisense targeting hepatic angiotensinogen). (renaissancecapital.com)
- Notes: Terms set; pricing targeted for the week of June 17, 2026, subject to market conditions. (renaissancecapital.com)
- Sources: Renaissance Capital — US IPO Week Ahead (June 12, 2026), SEC — Kardigan Form S‑1 (filed May 26, 2026)
Texas Ventures Acquisition IV Corp. (TVIV)
- Expected listing date: 2026-06-18
- Price range: $10.00 (units)
- Shares offered: 15,000,000 units
- Exchange: Nasdaq
- Business summary: Blank‑check company (SPAC) targeting industrial technology (software, IoT, energy transition, logistics, cloud/cyber) for a future business combination. (stockanalysis.com)
- Notes: Underwriters not clearly disclosed in publicly accessible filings; S‑1/A shows an active registration, and calendar places listing around June 18, 2026. SPAC IPO timing can shift quickly. (sec.gov)
- Sources: StockAnalysis — IPO Calendar (week of June 17–21, 2026), SEC — Texas Ventures Acquisition IV Corp. Form S‑1/A
MetaOptics Ltd (MOT)
- Expected listing date: 2026-06-19
- Price range: $5–$7 (ADS)
- Shares offered: 3,000,000 ADS
- Exchange: Nasdaq
- Lead underwriters: Roth Capital Partners, The Benchmark Company
- Business summary: Singapore‑based metalens and metaoptics company designing and manufacturing ultra‑thin flat optical lenses and related camera modules; vertically integrated across equipment, foundry, products and AI‑enabled metaoptics. (stockanalysis.com)
- Notes: Some calendars list June 18; issuer communications and F‑1 filings confirm an active process—date may shift. Underwriter names referenced in issuer announcements related to the F‑1. (sec.gov)
- Sources: StockAnalysis — MetaOptics (MOT), Renaissance Capital — MetaOptics sets/files for US IPO, SEC — MetaOptics Form F‑1 index, Singapore Exchange issuer announcement re F‑1 and underwriters
DPC Holdings PLC (Doncasters Group) (DPC)
- Expected listing date: 2026-06-25
- Price range: $28–$32
- Shares offered: 23,333,333 ordinary shares (+30‑day option)
- Exchange: NYSE
- Lead underwriters: Jefferies, Morgan Stanley, Barclays, Moelis & Company, RBC Capital Markets, Rothschild & Co
- Business summary: Leading independent manufacturer of complex precision‑cast engine components and nickel/cobalt‑based superalloys serving aero engines and industrial gas turbines; proceeds to repay debt (incl. shareholder PIK loan) and for general corporate purposes. (businesswire.com)
- Notes: Roadshow launched June 14, 2026; terms and timing subject to market conditions. Initial filing press release identified the full bookrunner group. (businesswire.com)
- Sources: Business Wire — Doncasters launches US IPO roadshow (June 14, 2026), Business Wire — Doncasters files S‑1 (May 26, 2026), StockAnalysis — DPC Holdings profile
Ticketplus Ltd (TP)
- Expected listing date: 2026-06-25
- Price range: $13–$15
- Shares offered: 1,800,000 shares
- Exchange: Nasdaq
- Lead underwriters: Bancroft Capital, Roth Capital Partners, MDB Capital Group
- Business summary: Latin American live‑event ticket marketplace and event software platform with full‑operations (Chile) and white‑label SaaS models generating transaction and licensing fees. (renaissancecapital.com)
- Notes: Date shown on some market calendars for June 25; issuer has set terms but has not publicly confirmed pricing date—subject to change. (investing.com)
- Sources: Renaissance Capital — Ticketplus sets terms (June 12, 2026), Investing.com — IPO calendar listing for Ticketplus
Joybyte Holdings Ltd (JOYB)
- Price range: $4–$6
- Shares offered: 6,300,000 shares
- Exchange: Nasdaq
- Lead underwriters: American Trust Investment Services (sole bookrunner)
- Business summary: Hong Kong‑based mobile gaming distribution platform (outside China) operating free‑to‑play titles monetized via ads and in‑app purchases; focuses on game marketing/monetization while licensing content from third‑party developers. (renaissancecapital.com)
- Notes: Terms set; no public pricing/listing date yet. Could slot into late June/early July subject to market conditions and SEC effectiveness. (renaissancecapital.com)
- Sources: Renaissance Capital — Joybyte sets terms (May 29, 2026)
ROKIT America, Inc. (RKAM)
- Price range: $8.50–$10.50
- Shares offered: 2,600,000 shares
- Exchange: Nasdaq
- Lead underwriters: Maxim Group LLC
- Business summary: US consumer health company selling NMN‑based anti‑aging dietary supplements; exploring AI‑enabled organ regeneration technologies via parent‑licensed IP. Products are dietary supplements (no FDA pre‑market approval). (renaissancecapital.com)
- Notes: Terms set; timing not announced. As a small‑cap consumer health issuer, scheduling may depend on market windows. (renaissancecapital.com)
- Sources: Renaissance Capital — ROKIT America sets terms (May 8, 2026)
IPO calendars change rapidly. Pricing/listing dates and share counts can move or be withdrawn, especially for SPACs and micro‑caps. Dates beyond late June are often not fixed more than 7–10 days in advance; treat ‘expected’ entries as tentative and confirm near the trade date. (stockanalysis.com)
Sources
- Stock Ratings: https://appleinsider.com/articles/26/05/26/new-380-bank-of-america-aapl-target-puts-ai-in-the-spotlight, https://ca.investing.com/news/stock-market-news/morgan-stanley-raises-apple-stock-price-target-to-360-on-ai-strategy-93CH-4681427, https://stockanalysis.com/stocks/aapl/forecast/, https://stockanalysis.com/stocks/msft/forecast/, https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-lowered-to-550-by-jpmorgan-on-valuation-93CH-4473038, https://www.investing.com/news/analyst-ratings/nvidia-stock-price-target-reiterated-at-250-by-goldman-sachs-93CH-4666748, https://www.marketbeat.com/instant-alerts/meta-platforms-nasdaqmeta-price-target-raised-to-77000-at-wells-fargo-company-2026-04-30/, https://www.marketbeat.com/instant-alerts/nvidia-nasdaqnvda-given-new-28000-price-target-at-jpmorgan-chase-co-2026-05-21/, https://www.marketbeat.com/instant-alerts/tesla-nasdaqtsla-upgraded-by-jpmorgan-chase-co-to-neutral-rating-2026-06-05/, https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/META/forecast/, https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/, https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/, https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/, https://www.reddit.com/r/NvidiaStock/comments/1pk4sqf/bofa_securities_has_reiterated_its_buy_rating_and/, https://www.streetinsider.com/Analyst+Comments/NVIDIA+(NVDA
- IPO Calendar: https://stockanalysis.com/ipos/calendar/, https://stockanalysis.com/stocks/mot/, https://stockanalysis.com/stocks/tviv/, https://www.businesswire.com/news/home/20260526375677/en/Doncasters-Files-Registration-Statement-for-Proposed-Initial-Public-Offering, https://www.businesswire.com/news/home/20260614384787/en/Doncasters-Announces-Launch-of-Initial-Public-Offering, https://www.investing.com/ipo-calendar/, https://www.renaissancecapital.com/IPO-Center/News/118899/Anti-aging-supplement-maker-ROKIT-America-sets-terms-for-%2425-million-IPO, https://www.renaissancecapital.com/IPO-Center/News/119425/Hong-Kong-based-mobile-gaming-platform-Joybyte-Holdings-sets-terms-for-%2431-, https://www.renaissancecapital.com/IPO-Center/News/119808/Latin-American-ticket-marketplace-Ticketplus-sets-terms-for-%2425-million-US-, https://www.renaissancecapital.com/IPO-Center/News/119814/US-IPO-Week-Ahead-Biotech-and-community-bank-set-to-follow-SpaceX%E2%80%99s-record-, https://www.sec.gov/Archives/edgar/data/0002096755/000121390026025455/ea0268724-02.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/1531193/000114036126022539/ny20062301x4_s1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2099681/0001213900-26-051378-index.htm?utm_source=openai
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-06-17 at 12:44 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI